-
Professor Georg Lenz: Exploring the revolution in DLBCL first-line treatment
Time of Update: 2023-01-06
Question 2: Before Pola reimbursement, what do you think is the most suitable treatment population for untreated DLBCL patients?Professor Georg LenzFrom subgroup analysis data, Pola-R-CHP regimens showed more significant benefit in patients with high-risk factors such as IPI score 3 to 5, age > 60 years, double expression, and ABC subtype, and may be biased towards these patients before reimbursement.
-
Professor Georg Lenz: Exploring the revolution in DLBCL first-line treatment
Time of Update: 2023-01-06
Question 2: Before Pola reimbursement, what do you think is the most suitable treatment population for untreated DLBCL patients?Professor Georg LenzFrom subgroup analysis data, Pola-R-CHP regimens showed more significant benefit in patients with high-risk factors such as IPI score 3 to 5, age > 60 years, double expression, and ABC subtype, and may be biased towards these patients before reimbursement.
-
George Church's team publishes cover article: Safely implanting therapeutic genes into the human genome
Time of Update: 2022-02-17
Now, a collaboration of researchers at Harvard's Wyss Institute for Biologically Inspired Engineering, Harvard Medical School (HMS), and ETH Zurich, Switzerland, has developed a computational method to identify therapeutic genes with significantly higher safety and A GSH site that is persistently expressed in many cell types .
-
Comparison of genome sequencing studies of "Lonely George" and Aldabra elephant turtles.
Time of Update: 2020-08-06
According to two papers published online Thursday in nature ecology and evolution, scientists at Yale University in the United States have developed a new genome sequencing that promotes a human understanding of the size, longevity and evolutionary path of two giant tortoises, including the "Lonely George", an important symbol of global species conservation, and helps save other endangered species.
-
George clinical appoints James Cheong as CEO
Time of Update: 2020-02-13
February 13, 2020 / AP / -- James Cheong has been appointed chief executive officer of George clinical, an international clinical research organization driven by science Cheong was hired as coo in ear
-
George W. sledge, Jr., a renowned breast cancer expert and doctor of medicine, will join the Tessa therapeutics board of directors
Time of Update: 2018-12-25
George W Sledge, Dr Jr is Professor of Stanford University Medical Center and director of oncology department Dr sledge, who brings decades of experience and leadership in cancer research and drug dev
